Thermo Fisher Scientific Opens Doe & Ingalls Northeast cGMP Chemical Distribution Facility
Thermo Fisher Scientific Inc. has announced the opening of its new Doe & Ingalls Northeast cGMP chemical distribution facility to meet the growing demand for quality compliance, production chemical storage and supply chain services for the biopharmaceutical, life science and advanced technology markets.
“A secure, robust supply chain is crucial for manufacturers to remain competitive, reduce total cost of ownership and mitigate risk of supply interruption,” said Jeff Jochims, president, research and safety markets, Thermo Fisher Scientific. “Our new Doe & Ingalls facility offers customers the ability to ramp up or expand their production capabilities quickly and cost-efficiently. By leveraging our scale and depth of capabilities in production materials supply chain, our customers can focus their internal resources on what they do best — developing new pharmaceuticals and technologies.”
Located in Peabody, Mass., the 56,000 sq ft, state-of-the-art facility is designed to protect raw material integrity, control the flow of goods and deliver supply chain services. The facility is cGMP-compliant to assure products and processes are in strict compliance with regulatory agencies and meet and/or exceed standards for temperature control, audit log/documentation and product handling/sampling. Innovative supply chain services include
• Storage and warehousing of chemical and raw materials
• Dip tube exchange and temperature-controlled 2-8°C cold storage
• ISO Class 8 and Class 100 cleanrooms provide sampling services for sourcing and quality control (QC) testing of production chemical materials.
“We welcome and celebrate this expansion,” said Massachusetts Governor Deval Patrick. “This facility underscores Thermo Fisher’s commitment to the leading life sciences supercluster in the world.”
“We congratulate Thermo Fisher on the opening of the Doe & Ingalls site,” said Robert K. Coughlin, president and chief executive officer of MassBio, a life sciences trade organization. “This site will be an excellent resource for our members, many of whom are challenged to operate as a GMP-compliant operation when it’s time to scale up to pilot manufacturing. This facility will provide critical services to get them up and running, shortening the time it takes to get new products to market and to the patients who need them.”
Related News
-
News Pharmapack Awards 2024 Patient-Centric Design Award Winner – Dr Ferrer BioPharma
The 2024 Pharmapack Awards celebrated the best in innovation and design for the pharmaceutical packaging and drug delivery industry on January 24, 2024. -
News Women in Pharma: Minding the Gap at Pharmapack 2024
2024 marks the first year Pharmapack will host a Diversity track dedicated to bridging the gap within the pharmaceutical packaging and drug delivery sector. The track includes a panel discussion on 'Enabling Diversity in the Workplace,' focused... -
News Pharmapack Awards 2024 - Celebrating Packaging and Drug Delivery Innovation
The 2024 Pharmapack Innovation Awards ceremony celebrated the best in pharmaceutical packaging and drug delivery innovation at all levels. The awards were held on January 24, 2024 at the Paris Expo Porte de Versailles. -
News 2024 Pharma Industry Trends Outlook: Collaboration, Market Maturity, and Digital Futures
The annual CPHI Online 2024 Pharma Trends Outlook, in partnership with Arvato Systems, identifies 12 key industry trends shaping the life sciences industry in the coming year. -
News New Novo Nordisk AI hub for drug discovery to open in London, UK
Danish pharmaceutical giant Novo Nordisk will be opening an AI-based research facility in the heart of London to advance drug discovery operations. -
News BioNTech to begin mRNA vaccine manufacturing in Rwanda by 2025
German biotechnology company BioNTech has stated their intentions to begin production at their mRNA vaccine factory in Rwanda by 2025, which will mark the first foreign mRNA vaccine manufacturing site on the continent of Africa. -
News Women in Pharma: Looking back on 2023 and moving forward to 2024
In this monthly series, we interview women from across the pharmaceutical industry and supply chain to discuss the importance of gender diversity in healthcare, the workplace, and beyond. -
News CPHI Barcelona 2023: Partnering for Success – Managing Outsourcing Relationships to Optimise Manufacturing Operations
During CPHI Barcelona 2023, insightful content sessions offered attendees the chance to explore trending topics with expert speakers and panellists. Here, we summarise what the pharma industry and supply chain are talking about the most.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance